Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

 
Company - Domestic
 Search News  Or
Anke Biotechnology shares up 117.65% at debut on ChiNext

Oct. 30, 2009 (China Knowledge) - Anhui Anke Biotechnology (Group) Co Ltd<300009>, a bio-pharmaceutical maker, debuted on the ChiNext Board on the Shenzhen Stock Exchange today, becoming one of the first companies to trade on the Nasdaq-style board.

Shares of the company opened at RMB 37, a price 117.65% higher than the IPO price, while the Shenzhen Component Index opened 1.92% higher at 12427.10 points.

The company raised RMB 166 million by issuing 21 million shares, or 25% of the company’s enlarged capital. Sinolink Securities Co Ltd<600109> was the underwriter of the offering.

Anhui Anke Biotechnology, which specializes in developing, manufacturing and marketing pharmaceuticals and health-care products, posted RMB 143.92 million of operating revenue in the third quarter of this year, with net profit hitting RMB 35.87 million during the period.







Copyright © "2013" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services
 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved